Source: International Congress 2014 – Predictors
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zhumagalyieva, L. Karazhanova (Semey, Kazakhstan). Mukoregulatory drugs in treating COPD. Eur Respir J 2014; 44: Suppl. 58, 3617

Member's Comments

No comment yet.

Related content which might interest you: Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Inter-relationship of different types of respiratory symptoms in COPD Source: International Congress 2014 – Comorbidities Year: 2014 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014